SCHEMBL22375275

SCHEMBL22375275

CCCC(CC)C1(C)CCN(C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26466033 0.91 CHRM2 (0.35) —
SCHEMBL22375273 0.89 — —
SCHEMBL22375268 0.89 CHRM2 (0.33) —
SCHEMBL21350250 0.78 — —
SCHEMBL19564599 0.70 GNAI3 (0.36) —
SCHEMBL21770984 0.70 GNAI3 (0.36) —
SCHEMBL23103575 0.70 CHRM2 (0.35) —
SCHEMBL22375315 0.69 — —
SCHEMBL15730452 0.69 DRD4 (0.33) —
SCHEMBL13763200 0.69 DRD4 (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10959432-B2 Microbiocidal oxadiazole derivatives SYNGENTA PARTICIPATIONS AG (CH) 2021-03-30 — — US disclosed
US-20200267986-A1 Microbiocidal Oxadiazole Derivatives SYNGENTA PARTICIPATIONS AG (CH) 2020-08-27 — — US disclosed
Send feedback